This virtual conference welcomes a distinguished faculty summarizing the latest data presented at GI ASCO 2026.

Learning Objectives

• Evaluate adenocarcinoma pancreatic cancer management changes
• Review updates in neuroendocrine pancreatic cancer management
• Evaluate rectal cancer management and organ preservation

Target Audience
Medical oncologists, radiation oncologists, surgeons, internists, family practitioners, physicians, nurses and allied health professionals

Agenda

8:00am - 8:05am:
Welcome
Angela Alistar, MD
Medical Director of GI Medical Oncology at Atlantic Health Morristown Medical Center
Medical Director of the Phase 1 Breakthrough Treatment Center

8:05am - 9:00am:
Gastrointestinal Neuroendocrine Treatment Updates
Heloisa P. Soares, MD, PhD
Associate Professor at the Huntsman Cancer Institute (HCI) at University of Utah
Medical Director for the Clinical Trials Office

9:00am - 10:00am:
Organ Preservation in the Management of Rectal Neoplasms
Daniel Hunt, MD, FACS, FASCRS
Colon and Rectal Surgery
Atlantic Medical Group

10:00am - 11:00am:
Practice Changes in Pancreatic Cancer Management
Erkut Borazanci, MD
Medical Director of the Oncology Research Division
HonorHealth Research Institute

11:00am - 11:05am:
Close
Angela Alistar, MD
Medical Director of GI Medical Oncology at Atlantic Health Morristown Medical Center
Medical Director of the Phase 1 Breakthrough Treatment Center

Accreditation/Designation Statement
Atlantic Health is accredited by the Medical Society of New Jersey to provide continuing medical education credits for physicians.
Atlantic Health designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Daniel H Hunt MD, FACS, FASCRS

Colon and Rectal Surgery, Atlantic Medical Group

Appearances